Literature DB >> 26524987

Basic Opioid Pharmacology.

John Williams1.   

Abstract

Opioids can be classified according to their mode of synthesis into alkaloids, semi-synthetic and synthetic compounds.There are three classical receptors (DOP, KOP and MOP). The novel NOP receptor is considered to be a non-opioid branch of the opioid receptor family.Opioids can either act as agonists, antagonists or partial agonists at these receptors.Opioid agonists bind to G-protein coupled receptors to cause cellular hyperpolarisation.MOP receptor agonists act in the central and peripheral nervous system to elicit analgesia.

Entities:  

Year:  2008        PMID: 26524987      PMCID: PMC4589929          DOI: 10.1177/204946370800100202

Source DB:  PubMed          Journal:  Rev Pain


  10 in total

Review 1.  Chronic opioid therapy for non-cancer pain.

Authors:  B J Collett
Journal:  Br J Anaesth       Date:  2001-07       Impact factor: 9.166

2.  A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin.

Authors:  Z Pan; N Hirakawa; H L Fields
Journal:  Neuron       Date:  2000-05       Impact factor: 17.173

Review 3.  Recent advances in selective opioid receptor agonists and antagonists.

Authors:  Masakatsu Eguchi
Journal:  Med Res Rev       Date:  2004-03       Impact factor: 12.944

Review 4.  Attacking pain at its source: new perspectives on opioids.

Authors:  Christoph Stein; Michael Schäfer; Halina Machelska
Journal:  Nat Med       Date:  2003-08       Impact factor: 53.440

5.  75 years of opioid research: the exciting but vain quest for the Holy Grail.

Authors:  Alistair D Corbett; Graeme Henderson; Alexander T McKnight; Stewart J Paterson
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 6.  Stimulatory effects of opioids.

Authors:  C Harrison; D Smart; D G Lambert
Journal:  Br J Anaesth       Date:  1998-07       Impact factor: 9.166

Review 7.  International Union of Pharmacology. XII. Classification of opioid receptors.

Authors:  B N Dhawan; F Cesselin; R Raghubir; T Reisine; P B Bradley; P S Portoghese; M Hamon
Journal:  Pharmacol Rev       Date:  1996-12       Impact factor: 25.468

Review 8.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

9.  Morphine, the Proteus of organic molecules.

Authors:  Paul R Blakemore; James D White
Journal:  Chem Commun (Camb)       Date:  2002-06-07       Impact factor: 6.222

10.  Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice.

Authors:  Soichiro Ide; Masabumi Minami; Masamichi Satoh; George R Uhl; Ichiro Sora; Kazutaka Ikeda
Journal:  Neuropsychopharmacology       Date:  2004-09       Impact factor: 7.853

  10 in total
  2 in total

Review 1.  Endogenous Opioids and Their Role in Stem Cell Biology and Tissue Rescue.

Authors:  Giovannamaria Petrocelli; Luca Pampanella; Provvidenza M Abruzzo; Carlo Ventura; Silvia Canaider; Federica Facchin
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

2.  Predictive Models to Identify Small Molecule Activators and Inhibitors of Opioid Receptors.

Authors:  Srilatha Sakamuru; Jinghua Zhao; Menghang Xia; Huixiao Hong; Anton Simeonov; Iosif Vaisman; Ruili Huang
Journal:  J Chem Inf Model       Date:  2021-05-28       Impact factor: 6.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.